BioCentury
ARTICLE | Company News

Biogen Idec, MAKScientific deal

March 19, 2012 7:00 AM UTC

MAKScientific granted Biogen Idec an option to license exclusive, worldwide rights to develop and commercialize discovery-stage products for multiple sclerosis (MS) and neurodegenerative diseases. Upo...